Cost-effectiveness of ustekinumab in moderate to severe Crohn’s disease in Sweden information for practice, 03 Aug 2018 Human monoclonal antibody ustekinumab is a novel Crohn’s disease (CD) treatment blocking pro-inflammatory cytokines interleukin-1…